More claims that J&J knew of hip implant troubles long before issuing a recall

Mass Device

April 1, 2013 by Arezu Sarvestani

Testimony in a the 2nd trial against Johnson & Johnson and its DePuy subsidiary again suggests that the medical device giant knew of potential defects in its metal-on-metal hip implants long before issuing a recall.
 

New testimony from the 2nd personal injury lawsuit to go to trial against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics mirrored an earlier case in delivering suggesting that the company may have known about potential defects in its metal-on-metal hip implants long before issuing a recall.

Testimony offered last week by former DePuy marketing director Paul Berman claimed that internal emails sent more than a year prior to the initial recall of the ASR XL metal hip implants warned that the product might be defective in design.